MAPS co-sponsors SABI Mind survey on the psychedelic experience

psychedelics study: Photo of Liberty caps in the forest

The internationally recognized non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) seeks to understand how and why people are tripping. In partnership with SABI Mind, Mind Medicine Australia, and Tiny, MAPS released a global survey that aims to take a well-rounded look at the psychedelic experiences of real people.

The goal is to provide researchers, policymakers, and advocates with a comprehensive understanding of the role of entheogens in the average psychonaut’s physical and mental well-being.

“The Global Psychedelic Survey will give us crucial information about how most people consume psychedelics, which is outside of clinical research and the medical system. This is a great way for us to learn from people’s lived experiences and make evidence-based decisions,” said MAPS founder and president Rick Doblin, Ph.D., in a press release.

The survey is available in English for participants over 21 and takes about 30 minutes to complete. The first questions cover the kinds of psychedelics most used, frequency of use, and substances that are often combined.

In addition, queries explore how making and listening to music plays a role in these experiences, what environments are ideal for specific trips, and whether activities like meditation and yoga bode well while under the influence.

Lastly, the survey covers how psychedelic journeys have impacted the traveler’s mental and physical well-being and the longevity of those results.

Psychedelic Science Conference comes to Denver

Results will be available in academic journals, presented at scientific conferences, and shared at public meetings, but participants will maintain anonymity. The survey will remain open until June 2, 2023. A few weeks later, MAPS will host the fourth annual Psychedelic Science Conference in Denver, CO.

GreenState will cover the conference that spotlights topics like harm reduction, psychedelic clinical trials, and societal acceptance of these therapies. Programming for the event seeks to answer basic questions like “How do psychedelics work?” and more complex topics like ethical considerations for psychedelic therapists and practitioners. Attendees can catch celebrity guests like Melissa Etheridge, Michael Pollan, and myconaut Paul Stamets during the five day community event..

Studies and conferences on psychedelics fuel the conversation as it moves out of the counterculture following the decriminalization of psilocybin in various cities and states. The more data collected and clinical trials completed, the better for formulating effective, non-harming psychedelic therapies for interested patients.

EDITOR’S NOTE: This article headline has been updated to clarify that MAPS is not conducting the survey on psychedelic experiences. SABI Mind is conducting the study and MAPS is a co-sponsor on the project. 

Cara Wietstock is Senior Content Producer of and has been working in the cannabis space since 2011. She has covered the cannabis business beat for Ganjapreneur and The Spokesman Review. You can find her living in Bellingham, Washington with her husband, son, and a small zoo of pets.